�����(%'*��&,��

������� ��"#!����

�� �

��)��&,+�$*.20/-1 �3 ���� ���

2018�6�10� ��

�������������� ����

�#

��/?8��7-,2@���"@��$�7;=��8��'�/��8����7-,20>92%!3+=*

1.16/<@��������658������4 �/)�1&�/�(6�:�,*

LS^~�Papanicolaoul1942�|3V9yh��Papanicolau9�EXr�R�1943�|��fDC�y@�LS�� ru}l���yh�g��y~�1971�}LS^,1}�y*��GD}LS^5^<~92�z`���xi�gzp�l��T~\�F|H[ym�>4}c&K�l�n�+bLS^}%Z'lA�[q�upz|���TLS^}0�la�ugrkr��TD6�<l$�rOoxi�;8�d��2000��#rx�Tl�4^l�eq���TLS^}&?zt})2l� q�xmxi���gt}u��Y}�{i�TLS^}��(Ql�rxi�g

��Iuv~�"J|jo��TLS^.WC�|wixU ^-zLS^j��B=MP^-N2z�7_�4]ru}y� s�g

��LS^������ 2015�!: /1U LS��

0

10

20

30

40

0- 10- 20- 30- 40- 50- 60- 70- 80- 90-

� �

�71��101�

����67.2�

2013�1��(2017�12�'"%���-�)�&������$#��+*.�������, � !172�

��

77

49

1927

���"! � ���

��� �!�

��� ��

61

3930

26

14 4

� ���� ���

���� �� ��

�������"��

� +,(

���.� �/ ��������.Liquid based cytology, LBC�/

**)'-&��!$#PAS��

���%10�����

2005 WHO Classification�WHO dysplasia grade)

Squamousintraepithelial neoplasia

2015 JSCC guideline Pap. Classification

Squamous cell hyperplasia Indefinite for neoplasia NILM Class II

Mild dysplasia SIN1Low-grade

SIN

LSIL Class II�Class III

Moderate dysplasia SIN2 LSIL (/HSIL) Class III

HSIL Class III(Severe dysplasia)(CIS; JSOP) SIN3

High-grade SIN

Carcinoma in situ SIN3 HSIL Class III!Class V

�2015���������������������

��� ����������������������

1.3'�/05D����OQP#��6$ Oinadequate)ORP#�6$ (adequate)QP$�=HF���;I<E�,�(�G��2)��>B<

NILM (negative for intraepithelial lesion or malignancy) (Class IVII-�PRP�&���,�2)�(�;I<E�,&��-�

LSIL (Low-grade squamous intraepithelial lesion or low-grade dysplasia) (Class IIbVIII-�)SP:&���,�2)(�;I<E�,&��-�

HSIL (high-grade squamous intraepithelial lesion or high-grade dysplasia)(Class IIIbVIV-�)TP���,*

SCC (squamous cell carcinoma) (Class V-�)UP7�8O/0�+C2)�;I<E92)�A� ?>@<P

INF (indefinite for neoplasm)O2015��%!"4�/0��CHI/05KJLMJNP

���������

���!

������

Normal (NILM) ��� �����LSIL

��� �����HSIL

SCC

��

Class II Class IIb+III Class IIIb+IV Class V

(*) (**) (**)

(2015� ���������� "���$#%&#')

�����$ &)

743:

-� &)

Normal (NILM) � ��$�!�LSIL

2 ��$�!�HSIL

SCC

74

'/,���

���1��

�1��#8�56�(

�1���1

ACB ACCB ACCB

�%."� or *�%�

*�%� or 2��"�0

2��"�0

A2015�����+�&) �89;&).=<>?<@B

��������/�������

����

SCC CIS Fibrous hyperplasia

Pyogenicgranuloma

epulis

Class V 9 3 2 1Class IV 1 0Class III 10 5 3 2Class II 16 2 1 1Class I 10 3 1 2SCC 5 1 1HSIL 3 2 2LSIL 4 2 1 1NILM 17 1 1

inadequate 2 1 1

�� 77 20 14 6 3 5 3

������������

�������

�/�������

�����

CIS dysplasia mild

erosive stomatitis

oral melanosis with

hyperkeratosis

Class V 1 1 1

Class IV 0 0

Class III 5 2 1 1

Class II 11 1 1Class I 20 1 1SCC 0 0HSIL 2 2 2LSIL 5 4 2 1 1NILM 5 1 1�� 49 11

�������

������ �/�� ����

�����

lichen planus stomatitis

Class II 8 2 2

Class I 7 1 1

NILM 4 2 2

�� 19 5

����������

���$�%��/���$�%

������

CIS epithelial & fibrous

hyperplasia

chronicperiodontitis/ mucositis/

inflammation

epulis/ papilloma

Class III 3 2 1 1

Class II 12 5 1 2 2

Class I 8 0

LSIL 0 0

NILM 4 1 1

�� 26 8

����'���$�� &�� #!"�&�����%

8���.��!7!�65&��077�9��49�9������19�9���-,27�*�)&�

8��!7!�65&��/����0SCC 5�9Class V 9�9Class IV 1�9Class III 3�9Class II 16�9Class I 10�9HSIL 3�9LSIL 4�9NILM 18�*�)&�8%/ ( �020�.��$9�����!12�9����!6��)&�8�����/��*09���*Class V4SCC, HSIL/��'#*-"9Class III4LSIL/��3�2&�8����/��*09���*0Class V/��'#*-"9

Class III, II, I*�)&��3�2&�

1+2

9�����)/Class V 1�: Class III 5�: Class II 11�:Class I 20�:HSIL 2�:LSIL 5�:NILM 5�)�(%�9$.�'�/11�-��#:���� 7��(%�9$85.��)/���)Class V3HSIL.��&"),!:

LSIL, NILM.��2�1%�

9��,+.��)/: Class III 3�:Class II 12�:Class I 8�:NILM 4�)�(%�$.�'�/8�-��#:���� 1��6:$.��/���)Class III)�(%�

9���)class III:II:I:�7�/LSIL:NILM.��)2:�-47 ����� ��*��58%�

0*1

���class III$II$I$�"��LSIL$NILM��������$��� "��������� �!#��

��